Navigation Links
Osteoporosis Drugs Might Not Raise Cancer Risk
Date:4/22/2009

Two studies suggest bisphosphonates don't increase chances of esophageal tumors

WEDNESDAY, April 22 (HealthDay News) -- Two new studies find that the class of osteoporosis drugs known as bisphosphonates may not, in fact, raise the risk of esophageal cancer.

This is in contrast to news earlier this year that the U.S. Food and Drug Administration had received reports of 23 patients taking the oral bisphosphonate Fosamax (alendronate), who had been diagnosed with cancer of the esophagus.

Bisphosphonates have come under scrutiny in recent years for a variety of other possible problems, including an increased risk of atrial fibrillation (a type of abnormal heart rhythm), unusual fractures of the thigh bone, jaw necrosis and inflammatory eye disease.

But the big picture is still unclear, and patients taking the drug, which reduces the risk of fractures related to the bone-thinning condition osteoporosis, should not change their practices, several experts noted.

"The adverse affects reporting agency [where the FDA first heard of the cases] only reports cases but does not look at the science behind it," said Dr. Robert C. Ashton Jr., director of minimally invasive thoracic surgery at Montefiore Medical Center in New York City. "Given the wide use of bisphosphonates and low incidence of esophageal cancer overall, individuals should continue taking them and discuss any concerns with there doctors."

"Don't panic," echoed Dr. Daniel H. Solomon, lead author of one of the new reports being published as a letter-to-the-editor in the April 23 issue of the New England Journal of Medicine. "A series of cases is useful to prompt an epidemiologic study but it should not be used to guide prescribing."

Solomon's analysis of 1,000 patients found no increased risk of esophageal cancer although, he pointed out, the cancer is a rare one, and even this large a study might not have detected a heightened ri
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Link between widely used osteoporosis drugs and heart problems probed
2. Access to Osteoporosis Testing for Americans in Jeopardy
3. Upcoming Symposium to Bridge the Gap between Osteoporosis Research and its Applications to Clinical Practice with Focus on Secondary Osteoporosis, Osteoporosis in Men, and Lessons from Space Travel for Improving Bone Health
4. Latest Osteoporosis Research Translated for Health Professionals to Use in Clinical Setting
5. ADA Informs Patients About Osteoporosis Medications and Oral Health
6. Time for Change - Sunshine and Exercise Part of Holistic Treatment for Osteoporosis
7. Stem cells could halt osteoporosis, promote bone growth
8. CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
9. Study Links Osteoporosis Drugs to Jaw Trouble
10. Osteoporosis Drug Prompts Increase in Certain Bone Cells
11. Study Shows Exercise Shields Against Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Osteoporosis Drugs Might Not Raise Cancer Risk
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® will team ... America (HCA), as it further expands its Strategic Alliance Partnership Program for raising ... new partnership, OncLive’s editorial and marketing teams will collaborate with Sarah Cannon to ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse Show hosted ... 11, 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event ... petting zoo, an Elvis impersonator, a silent auction and concessions. , Horses and riders ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... author Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... 17 years who participated in the National Survey on Drug Use and Health, ...
(Date:7/1/2015)... ... 2015 , ... Element Blue ™, a leading IT ... has received trademark protection for its SensorInsight® computer software platform. SensorInsight® is used ... sources providing an environment where users can view and compare real-time and historic ...
(Date:7/1/2015)... ... July 01, 2015 , ... Bunion Bootie, the newest and ... two or more Bunion Booties directly from their website, http://www.BunionBootie.com can ... misaligned toes and its ultra thin properties allow for protection against rubbing footwear ...
Breaking Medicine News(10 mins):Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2
... Researchers from MetroHealth Medical Center and Case Western Reserve ... who have had previous spontaneous preterm births with 17 ... another preterm birth would consequently reduce both short-term and ... year. The results of their study are reported in ...
... medication labels in languages other than English, few New ... limited-English patients face serious risk of medication error, according ... Medicine presented today at the annual meeting of the ... ,"Imagine, as an English speaker, picking up ...
... out of three sexually active older adults infected with HIV ... researchers//. A survey of 260 HIV-positive older adults found that ... were in a relationship. ,AIDs cases among the ... for Disease Control and Prevention, they will account for half ...
... the potential for medication errors, says a new study by ... May issue of the journal Medical Care. ,The ... College of Pharmacy professor Daniel C. Malone, Ph.D., who is ... Research on Therapeutics at the Critical Path Institute. ...
... for their antiretroviral medications experienced interruptions in drug ... logistical disruptions. These treatment interruptions led to the ... ,These findings by a team led ... Makerere University, Kampala, and UCSF are reported in ...
... of global warming keeps coming up from across the world. ... seawaters are killing marine life in their thousands. ... ago it was reported that a Norwegian glacier had shrunk ... a usually frozen fjord (a long narrow arm of ...
Cached Medicine News:Health News:Drug Therapy can Reduce Preterm Births and Decrease Lifetime Medical Costs 2Health News:Many NYC Pharmacies Fail to Translate Prescription Labels for Patients Who Don't Understand English 2Health News:Many NYC Pharmacies Fail to Translate Prescription Labels for Patients Who Don't Understand English 3Health News:One-Third of Sexually Active Older Adults With HIV/AIDs Has Unprotected Sex 2Health News:Pharmacists' Workload Contributes To Errors 2Health News:Resistance to Anti-HIV Drugs in Uganda Developed Due to Drug Supply Problems 2Health News:Norwegian Glacier Shrinks and Marine Life Poisoned as the Globe Warms 2Health News:Norwegian Glacier Shrinks and Marine Life Poisoned as the Globe Warms 3
(Date:7/1/2015)... , July 1, 2015 OncoSec Medical Inc. ("OncoSec") ... immunotherapies, today announced that CEO and President Punit Dhillon ... the Company,s listing to The Nasdaq Stock Market at 9:30 ... in New York City .   ... and stakeholders, we are honored to open the Nasdaq to ...
(Date:7/1/2015)... PISCATAWAY, New Jersey , July 1, 2015 ... Centre (CCDC) celebrates 50 years of the Cambridge ... the launch of new software in the CSD-System ... the world,s most comprehensive collection of crystal structure ... interaction analysis, geometry analysis, and support for tailored ...
(Date:6/30/2015)... SANTA MONICA, Calif. , June 30, 2015 /PRNewswire/ ... th consecutive year, is an event dedicated to ... on the hottest issues and topics affecting the industry ... designed to address the challenges and opportunities facing today,s ... For more information and to register for MEDevice San ...
Breaking Medicine Technology:OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 2OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 3Scientific Symposium and New Software for Crystallographers and Scientists Worldwide to Celebrate 50 Years of the Cambridge Structural Database 2Scientific Symposium and New Software for Crystallographers and Scientists Worldwide to Celebrate 50 Years of the Cambridge Structural Database 3MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2
... ARBOR, Mich., Aug. 6 Terumo Heart, Inc. ... Left Ventricular Assist,System (LVAS) took place on July ... Ann Arbor, Michigan. The surgery was performed by,Francis ... U.S. Pivotal Trial. DuraHeart is the world,s first ...
... held on Wednesday, August 6, 2008 at 8:00 ... ... Isolagen(TM), Inc. (Amex:,ILE) announced today positive top-line efficacy and safety results from ... for the treatment of nasolabial folds, or wrinkles.,Each study, conducted under an ...
Cached Medicine Technology:First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial 2Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 2Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 3Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 4Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 5
Compact, bench-top analyser with minimal water volume requirements and easy waste management....
Compact benchtop clinical chemistry system...
... offers easy operation, maintenance, and training. Whether you ... to the powerful VITROS 5,1 FS, the VITROS ... right the first time. Its that simple. , ... and easy-to-use. The VITROS 350 comes complete with ...
Meet Galileo, the best reason to move to automation; the best way to upgrade your capabilities....
Medicine Products: